311 related articles for article (PubMed ID: 2133242)
1. Detection of lupus anticoagulant by means of dilute Russell's viper venom time is affected by oral anticoagulant therapy.
Jouhikainen T
Blood Coagul Fibrinolysis; 1990 Dec; 1(6):627-32. PubMed ID: 2133242
[TBL] [Abstract][Full Text] [Related]
2. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
[TBL] [Abstract][Full Text] [Related]
3. Warfarin does not interfere with lupus anticoagulant detection by dilute Russell's viper venom time.
Olteanu H; Downes KA; Patel J; Praprotnik D; Sarode R
Clin Lab; 2009; 55(3-4):138-42. PubMed ID: 19462936
[TBL] [Abstract][Full Text] [Related]
4. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
Moore GW; Rangarajan S; Savidge GF
Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
[TBL] [Abstract][Full Text] [Related]
5. Coagulation tests and anti-phospholipid antibodies in patients positive for lupus anticoagulant.
Sakakura M; Wada H; Watanabe R; Mamamuro M; Okugawa Y; Nakasaki T; Nakase T; Wakita Y; Minamikawa K; Mori Y; Nshikawa M; Shiku H
Clin Appl Thromb Hemost; 2000 Jul; 6(3):144-50. PubMed ID: 10898274
[TBL] [Abstract][Full Text] [Related]
6. Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism.
Morelli VM; Rodrigues CA; Noguti MA; Matos MF; da Silveira RC; Ribeiro AA; Lourenço DM
Blood Coagul Fibrinolysis; 2007 Jul; 18(5):401-5. PubMed ID: 17581313
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of lupus anticoagulant (LA) antibodies: LA activity in dilute Russell's Viper Venom Time and dilute Kaolin Clotting Time detect different populations of antibodies in patients with the "antiphospholipid" syndrome.
Kandiah DA; Krilis SA
Thromb Haemost; 1998 Aug; 80(2):250-7. PubMed ID: 9716148
[TBL] [Abstract][Full Text] [Related]
8. Comparison of test methods for the lupus anticoagulant: international survey on lupus anticoagulants-I (ISLA-1).
Exner T; Triplett DA; Taberner DA; Howard MA; Harris EN
Thromb Haemost; 1990 Nov; 64(3):478-84. PubMed ID: 2128977
[TBL] [Abstract][Full Text] [Related]
9. Newly developed dilute Russell's viper venom reagents for lupus anticoagulant detection with improved specificity.
Moore GW; Peyrafitte M; Dunois C; Amiral J
Lupus; 2018 Jan; 27(1):95-104. PubMed ID: 28549386
[TBL] [Abstract][Full Text] [Related]
10. [The positive rate of lupus anticoagulant according to the each understanding disease in our hospital].
Omote M; Yoshida T; Asakura H; Ontachi Y; Hayashi T; Morishita E; Yamazaki M; Fujita S; Nakao S
Rinsho Byori; 2006 Sep; 54(9):903-9. PubMed ID: 17063871
[TBL] [Abstract][Full Text] [Related]
11. Lupus anticoagulants: pathogenesis and laboratory diagnosis.
Court EL
Br J Biomed Sci; 1997 Dec; 54(4):287-98. PubMed ID: 9624740
[TBL] [Abstract][Full Text] [Related]
12. [Detection of lupus anticoagulant using a modified diluted Russell's viper venom time test].
Sato K; Kagami K; Asai M; Nakashima N; Takamatsu J
Rinsho Byori; 1995 Mar; 43(3):263-8. PubMed ID: 7745832
[TBL] [Abstract][Full Text] [Related]
13. Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA.
Tripodi A; Chantarangkul V; Clerici M; Mannucci PM
Thromb Haemost; 2002 Oct; 88(4):583-6. PubMed ID: 12362227
[TBL] [Abstract][Full Text] [Related]
14. Alteration in the laboratory profile of a lupus anticoagulant in a patient with non-Hodgkin's lymphoma.
Moore GW; Kamat AV; Gurney DA; O'Connor O; Rangarajan S; Carr R; Savidge GF
Clin Lab Haematol; 2004 Dec; 26(6):429-34. PubMed ID: 15596003
[TBL] [Abstract][Full Text] [Related]
15. The risk of thrombosis in patients with lupus anticoagulants is predicted by their specific coagulation profile.
Galli M; Finazzi G; Norbis F; Marziali S; Marchioli R; Barbui T
Thromb Haemost; 1999 May; 81(5):695-700. PubMed ID: 10365739
[TBL] [Abstract][Full Text] [Related]
16. Laboratory identification of lupus anticoagulants using the combination of activated partial thromboplastin time and Russell's viper venom at two phospholipid concentrations.
Akkawat B; Chantarangkul V; Rojnuckarin P; Juntiang J
J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S451-8. PubMed ID: 12930024
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of Russell's viper venom affects the sensitivity of the dilute Russell's viper venom time to lupus anticoagulants.
Moore GW; Savidge GF
Blood Coagul Fibrinolysis; 2004 Apr; 15(3):279-82. PubMed ID: 15060428
[TBL] [Abstract][Full Text] [Related]
18. The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulant show marked differences in performance between photo-optical and mechanical coagulometers.
Lawrie AS; Mackie IJ; Purdy G; Machin SJ
Thromb Haemost; 1999 May; 81(5):758-62. PubMed ID: 10365750
[TBL] [Abstract][Full Text] [Related]
19. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies.
Pengo V; Biasiolo A; Rampazzo P; Brocco T
Thromb Haemost; 1999 Feb; 81(2):256-8. PubMed ID: 10064002
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of four coagulation tests to detect plasma lupus anticoagulants.
Saxena R; Saraya AK; Kotte VK; Singh YN; Prasad L; Malviya AN
Am J Clin Pathol; 1991 Dec; 96(6):755-8. PubMed ID: 1746492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
